Abstract Background Lung cancer often exhibits molecular changes, such as the overexpression of the ErbB1 gene. ErbB1 encodes epidermal growth factor receptor (EGFR), a tyrosine kinase receptor, involved mainly in cell proliferation and survival. EGFR overexpression has been associated with more aggressive disease, poor prognosis, low survival rate and low response to therapy. ErbB1 amplification and mutation are associated with tumor development and are implicated in ineffective treatment. The aim of the present study was to investigate whether the ErbB1 copy number affects EGFR expression, cell proliferation or cell migration by comparing two different cell lines. ...
[[abstract]][[abstract]]Controlled activation of epidermal growth factor receptor (EGFR) is systemat...
Introduction: Patients with non-small cell lung cancer (NSCLC) with cancers harboring activating mut...
AbstractOBJECTIVES: Contradicting results have been demonstrated for the expression of the epidermal...
Abstract Background Lung cancer often exhibits molecu...
Abstract Background Lung cancer often exhibits molecu...
Abstract Background Lung cancer often exhibits molecu...
Abstract Background Lung cancer often exhibits molecu...
Abstract Background ...
To clarify the pathogenic and biological significance of EGFR mutations in lung cancer, we compared ...
To clarify the pathogenic and biological significance of EGFR mutations in lung cancer, we compared ...
Lung cancer is the most common type of cancer in men and women worldwide, and it is the main cause o...
Summar- ErbB-2 and EGFR (epidermal growth factor receptor) are expressed in lung adenocarcinomas and...
[[abstract]]Controlled activation of epidermal growth factor receptor (EGFR) is systematically guara...
[[abstract]]Controlled activation of epidermal growth factor receptor (EGFR) is systematically guara...
[[abstract]][[abstract]]Controlled activation of epidermal growth factor receptor (EGFR) is systemat...
[[abstract]][[abstract]]Controlled activation of epidermal growth factor receptor (EGFR) is systemat...
Introduction: Patients with non-small cell lung cancer (NSCLC) with cancers harboring activating mut...
AbstractOBJECTIVES: Contradicting results have been demonstrated for the expression of the epidermal...
Abstract Background Lung cancer often exhibits molecu...
Abstract Background Lung cancer often exhibits molecu...
Abstract Background Lung cancer often exhibits molecu...
Abstract Background Lung cancer often exhibits molecu...
Abstract Background ...
To clarify the pathogenic and biological significance of EGFR mutations in lung cancer, we compared ...
To clarify the pathogenic and biological significance of EGFR mutations in lung cancer, we compared ...
Lung cancer is the most common type of cancer in men and women worldwide, and it is the main cause o...
Summar- ErbB-2 and EGFR (epidermal growth factor receptor) are expressed in lung adenocarcinomas and...
[[abstract]]Controlled activation of epidermal growth factor receptor (EGFR) is systematically guara...
[[abstract]]Controlled activation of epidermal growth factor receptor (EGFR) is systematically guara...
[[abstract]][[abstract]]Controlled activation of epidermal growth factor receptor (EGFR) is systemat...
[[abstract]][[abstract]]Controlled activation of epidermal growth factor receptor (EGFR) is systemat...
Introduction: Patients with non-small cell lung cancer (NSCLC) with cancers harboring activating mut...
AbstractOBJECTIVES: Contradicting results have been demonstrated for the expression of the epidermal...